These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review. Becker Y. Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271 [Abstract] [Full Text] [Related]
24. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. Hammond SA, Bollinger RC, Stanhope PE, Quinn TC, Schwartz D, Clements ML, Siliciano RF. J Exp Med; 1992 Dec 01; 176(6):1531-42. PubMed ID: 1460417 [Abstract] [Full Text] [Related]
25. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients. Safrit JT, Lee AY, Andrews CA, Koup RA. J Immunol; 1994 Oct 15; 153(8):3822-30. PubMed ID: 7523505 [Abstract] [Full Text] [Related]
26. Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones. Kurane I, West K, Tuazon CU, Zeng W, Ennis FA. J Clin Virol; 2003 May 15; 27(1):38-43. PubMed ID: 12727527 [Abstract] [Full Text] [Related]
28. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice. Lapham C, Golding B, Inman J, Blackburn R, Manischewitz J, Highet P, Golding H. J Virol; 1996 May 15; 70(5):3084-92. PubMed ID: 8627787 [Abstract] [Full Text] [Related]
29. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Takahashi H, Cohen J, Hosmalin A, Cease KB, Houghten R, Cornette JL, DeLisi C, Moss B, Germain RN, Berzofsky JA. Proc Natl Acad Sci U S A; 1988 May 15; 85(9):3105-9. PubMed ID: 2452443 [Abstract] [Full Text] [Related]
30. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A, Nagai Y, Iwamoto A, Matsuda Z, Ariyoshi K. J Virol; 2004 Feb 15; 78(3):1324-32. PubMed ID: 14722287 [Abstract] [Full Text] [Related]
31. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection. Borghan MA, Oka S, Takiguchi M. Tissue Antigens; 2005 Oct 15; 66(4):305-13. PubMed ID: 16185326 [Abstract] [Full Text] [Related]
32. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies. Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R. Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034 [Abstract] [Full Text] [Related]
33. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. Yang OO, Kalams SA, Rosenzweig M, Trocha A, Jones N, Koziel M, Walker BD, Johnson RP. J Virol; 1996 Sep 18; 70(9):5799-806. PubMed ID: 8709196 [Abstract] [Full Text] [Related]
34. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals. Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T. Viral Immunol; 2005 Sep 18; 18(4):627-36. PubMed ID: 16359229 [Abstract] [Full Text] [Related]
35. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL. Carmichael A, Jin X, Sissons P. J Virol; 1996 Dec 18; 70(12):8468-76. PubMed ID: 8970969 [Abstract] [Full Text] [Related]
36. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. Corbet S, Nielsen HV, Vinner L, Lauemoller S, Therrien D, Tang S, Kronborg G, Mathiesen L, Chaplin P, Brunak S, Buus S, Fomsgaard A. J Gen Virol; 2003 Sep 18; 84(Pt 9):2409-2421. PubMed ID: 12917462 [Abstract] [Full Text] [Related]
37. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. Hadida F, Parrot A, Kieny MP, Sadat-Sowti B, Mayaud C, Debre P, Autran B. J Clin Invest; 1992 Jan 18; 89(1):53-60. PubMed ID: 1370302 [Abstract] [Full Text] [Related]
38. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. Wizel B, Houghten RA, Parker KC, Coligan JE, Church P, Gordon DM, Ballou WR, Hoffman SL. J Exp Med; 1995 Nov 01; 182(5):1435-45. PubMed ID: 7595214 [Abstract] [Full Text] [Related]
39. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction. Bergmann CC, Tong L, Cua RV, Sensintaffar JL, Stohlman SA. J Immunol; 1994 Jun 15; 152(12):5603-12. PubMed ID: 7515908 [Abstract] [Full Text] [Related]
40. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. Johnson RP, Trocha A, Yang L, Mazzara GP, Panicali DL, Buchanan TM, Walker BD. J Immunol; 1991 Sep 01; 147(5):1512-21. PubMed ID: 1715361 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]